Computational Methods to Predict Drug Safety

By  

Current Computer - Aided Drug Design, Vol. 2, Iss. 2, 2006-06 ,pp. : 151-168

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacogenomic data submissions to the FDA: non-clinical case studies

By Leighton John K   DeGeorge Joseph   Jacobson-Kram David   MacGregor James   Mendrick Donna   Worobec Alexandra  

Pharmacogenomics, Vol. 5, Iss. 5, 2004-07 ,pp. : 507-511

Future Medicine

Access to resources Recommend Favorite

Mapping and Characterizing the Development Pathway from Non-Clinical through Early Clinical Drug Development

By Stergiopoulos Stella   Getz Kenneth A.  

Pharmaceutical Medicine, Vol. 26, Iss. 5, 2012-10 ,pp. : 297-307

Adis International

Access to resources Recommend Favorite

Joint EFPIA/CHMP SWP workshop: the Emerging Use of Omic Technologies for Regulatory Non-Clinical Safety Testing

By Kasper Peter   Oliver Gerry   Lima Beatriz Silva   Singer Thomas   Tweats David  

Pharmacogenomics, Vol. 6, Iss. 2, 2005-03 ,pp. : 181-184

Future Medicine

Access to resources Recommend Favorite

Method Validation and Measurement of Biomarkers in Nonclinical and Clinical Samples in Drug Development: A Conference Report

By Lee Jean W.   Weiner Russ S.   Sailstad Jeff M.   Bowsher Ronald R.   Knuth Dean W.   O’Brien Peter J.   Fourcroy Jean L.   Dixit Rakesh   Pandite Lini   Pietrusko Robert G.   Soares Holly D.   Quarmby Valerie   Vesterqvist Ole L.   Potter David M.   Witliff James L.   Fritche Herbert A.   O’Leary Timothy   Perlee Lorah   Kadam Sunil   Wagner John A.  

Pharmaceutical Research, Vol. 22, Iss. 4, 2005-04 ,pp. : 499-511

Springer Publishing Company

Access to resources Recommend Favorite